tebipenem and Long-QT-Syndrome

tebipenem has been researched along with Long-QT-Syndrome* in 1 studies

Trials

1 trial(s) available for tebipenem and Long-QT-Syndrome

Article	Year
Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Tebipenem Pivoxil Hydrobromide on QT/QTc Intervals in Healthy Subjects. Antimicrobial agents and chemotherapy, 2021, 06-17, Volume: 65, Issue:7 Tebipenem pivoxil hydrobromide (TBP-PI-HBr) is an orally available prodrug of tebipenem (TBP), a carbapenem with Topics: Carbapenems; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Long QT Syndrome	2021

Article

Year

Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Tebipenem Pivoxil Hydrobromide on QT/QTc Intervals in Healthy Subjects.

Antimicrobial agents and chemotherapy, 2021, 06-17, Volume: 65, Issue:7

Tebipenem pivoxil hydrobromide (TBP-PI-HBr) is an orally available prodrug of tebipenem (TBP), a carbapenem with

Topics: Carbapenems; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Long QT Syndrome

2021